Anbio Biotechnology Class A Ordinary Shares (NNNN)
NNNN Stock Price Chart
Explore Anbio Biotechnology Class A Ordinary Shares interactive price chart. Choose custom timeframes to analyze NNNN price movements and trends.
NNNN Company Profile
Discover essential business fundamentals and corporate details for Anbio Biotechnology Class A Ordinary Shares (NNNN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
19 Feb 2025
Employees
27.00
Website
https://www.anbio.comCEO
Michael Lau
Description
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.
NNNN Financial Timeline
Browse a chronological timeline of Anbio Biotechnology Class A Ordinary Shares corporate events including earnings releases, dividend announcements, and stock splits.
NNNN Stock Performance
Access detailed NNNN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.